|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/2803 | (2013.01) |
| A61K 39/00 | (2006.01) | ||
| A61K 35/17 | (2015.01) | ||
| C12N 5/0638 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61K2039/804 | (2018.08) | ||
| C12N 5/0783 | (2010.01) | ||
| A61K 39/001113 | (2018.08) | ||
| C07K 19/00 | (2006.01) | ||
| A61K2039/5156 | (2013.01) | ||
| C07K 14/47 | (2006.01) | ||
| A61K2039/5158 | (2013.01) | ||
| C07K2317/622 | (2013.01) | ||
| C07K2317/73 | (2013.01) | ||
| C07K2319/03 | (2013.01) | ||
| C07K2319/33 | (2013.01) | ||
| C07K2319/74 | (2013.01) | ||
| C07K 14/7051 | (2013.01) | ||
| C07K 14/70517 | (2013.01) | ||
| C07K 14/70578 | (2013.01) | ||
| C07K2319/02 | (2013.01) | ||
| C07K 14/47 | (2013.01) | ||
| C07K 19/00 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3592379 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18715024.8 |
| Date of filing the European patent application | 2018-03-30 | |
| (97) | Date of publication of the European application | 2020-01-15 |
| (45) | Date of publication and mention of the grant of the patent | 2024-04-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2018/058367 |
| Date | 2018-03-30 |
| (87) | Number | WO 2018/178377 |
| Date | 2018-10-04 |
| (30) | Number | Date | Country code |
| PA201770239 | 2017-03-31 | DK | |
| PA201770240 | 2017-03-31 | DK | |
| PA201770542 | 2017-06-30 | DK | |
| PCT/EP2017/076800 | 2017-10-19 | WO |
| (72) |
SMITH, Julianne , US
DUCHATEAU, Philippe , FR
DERRIEN, Murielle , FR
|
| (73) |
Cellectis SA ,
8 Rue de la Croix Jarry, 75013 Paris,
FR
|
| (54) | UNIVERSAL ANTI-CD22 CHIMERIC ANTIGEN RECEPTOR ENGINEERED IMMUNE CELLS |
| UNIVERSAL ANTI-CD22 CHIMERIC ANTIGEN RECEPTOR ENGINEERED IMMUNE CELLS |